Interestingly, the existence of a direct receptor-receptor interaction between A2AR and dopamine D2 receptor (D2R) in the striatum was recently demonstrated and proposed as a pharmacological target for PD management19. This evidence concerns the gene ADORA2A and Parkinson disease.